A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea

• Status: Completed
• Trial end date: 2015-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the efficacy of two Metronidazole Gels 1%, in the treatment of Rosacea.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: bioRASI, LLC
• Treatments: Metronidazole

Criteria

Inclusion Criteria:

• Male or Female subjects with at least 18 years of age;

• Read and signed ICF;

• Clinical Diagnosis of Rosacea;

Exclusion Criteria:

• Females who are pregnant, lactating or of childbearing potential who are not using or do not agree to use an acceptable form of contraception;

• Any skin condition that would interfere with treatment of rosacea

• Use of prohibited medications